Royalty Pharma plc - Ordinary Shares - Class A

NASDAQ:RPRX   3:59:51 PM EDT
43.66
+0.53 (+1.23%)
4:07:18 PM EDT: $42.76 -0.90 (-2.06%)
Debt Financing / Related

Blueprint Medicines Announces $1.25 Bln Strategic Financing Collaborations With Sixth Street And Royalty Pharma

Published: 06/30/2022 11:25 GMT
Royalty Pharma plc - Ordinary Shares - Class A (RPRX) - Blueprint Medicines Announces Transformative $1.25 Billion Strategic Financing Collaborations With Sixth Street and Royalty Pharma.
Blueprint Medicines Corp - Blueprint Medicines Will Receive $575 Million in Totalcash Funded at Close.
Blueprint Medicines Corp - Agreement With Sixth Street Includes Up to $400 Million in a Senior Secured Credit Facility.